Glenn Kerkhof is Executive Chairman and acting CEO of George Clinical. Glenn has over 22 years’ experience in the contract research or drug development industry and joined George Clinical from Chiltern where he was Chief Executive Officer. Prior to Chiltern, Glenn served as Vice President, Clinical Services for Charles River Laboratories and as Vice President, Clinical Europe for Inveresk Research. In addition, he is also non-executive director of Cell Care Australia Pty. Ltd. and Immunoglobal Pty. Ltd. He holds a Bachelor of Commerce from Deakin University (Australia) and a Masters of Business Administration from the University of Edinburgh (UK).
James Cheong is Chief Operating Officer of George Clinical. James has significant business leadership experience and more than 20 years of industry experience in both global pharma and CRO companies in the areas of Clinical Operations, Regulatory Affairs, Data Science and Regional Management. Prior to George Clinical, Cheong served as Head of Clinical Operations for the Chinese Market for Boehringer Ingelheim. Prior to Boehringer Ingelheim, Cheong acted as VP of Clinical Development at EPS International in the Asia-Pacific region. Based in our Singapore office, James leads global operations and directs the company’s administrative functions.
Amanda is responsible for the project management and clinical operations teams to deliver George Clinical’s studies to the highest standards. Amanda has over 25 years’ experience implementing clinical trials across the Asia-Pacific region and more than 20 years’ line management experience. Amanda has worked across all clinical trial phases and George Clinical’s therapy areas. Her previous management roles span both CROs and pharmaceutical companies and she has worked as an independent consultant.
Maria serves as the Chief Medical Officer for George Clinical, responsible for continuing to build the organization’s enviable network of investigators and scientific leaders. Previously, she lead the medical and safety services group at George Clinical who provide safety management, endpoint adjudication, medical monitoring and scientific leadership for both commercially sponsored and academic clinical trials. Maria has worked closely with the scientific leads at the George Institute to develop and implement scientific leadership models for George Clinical studies, as well as to develop new ideas for clinical research, and processes to improve clinical trial design and efficiencies. Maria has several years’ experience in both public health and clinical research as well as research management across a range of settings including hospitals, academic and clinical research organizations.
Sean Hart is the Managing Director USA and Global Head of Late Phase Studies for George Clinical. Prior to joining George Clinical, Sean was the Executive Vice President and Managing Director of Vector Oncology overseeing the Global Pharma Services team including early phase and observational research. Sean is a recognized industry leader in Phase IV clinical trials, post-marketing surveillance programs, and patient registries. His experience spans all major therapeutic areas and all phases of research and development.
Jacqueline is responsible for oversight of all contracting, insurance and legal activities for George Clinical and its subsidiaries and for leading risk management and corporate compliance for the global group. Jacqueline’s role includes management of Asia-Pacific country heads, Australia and New Zealand business operations and is company secretary. Jacqueline has extensive experience in business development and management having spent 25 years in the healthcare industry working in the biotechnology, diagnostic, pharmaceutical and CRO markets and has experience in intellectual property management.
Jeff completed his degrees (BS) in engineering (Aerospace as well as Mechanical) at the University of Missouri – Rolla in 1992. Instead of the engineering field, Jeff pursued pharmaceutical research from 1993 onward. For over 22 years, Jeff led the clinical data management group as well as statistics, statistical programming, medical writing, and IT infrastructure and development at United BioSource Corporation. This group grew over the years from one location and 3 employees in 1993 to 4 locations and over 100 employees within the data management and biostats groups. Jeff has focused on systems development and programming throughout his career with an emphasis on CTMS, EDC, EMR, as well as other electronic systems focused on improving clinical care and research.
Harmony leads the Human Resources (HR) team globally to effectively partner with the organization to deliver on its people and company objectives. Harmony has over 10 years of talent acquisition and generalist HR experience across the Life Sciences, IT&T and Built Environment industries globally and is MBA qualified in addition to holding a BA (Organizational Learning) and being Training & Assessment certified.
Philip has over 23 years’ experience in pharmaceutical marketing in mainstream pharmaceutical companies, biotechnology and medical devices. He has held senior management roles in international marketing, brand and business development and strategic portfolio development. Philip has worked in several countries including the US, UK, Japan, Australia and China and has worked in Asia for over 18 years, the last ten years in China. Philip is the Managing Director of George Clinical China and Head of Business Development and Sales for Asia-Pacific developing our business and customers throughout the region.
Vanaja has a Master’s degree in Commerce and professional qualifications in both cost & financial management and corporate compliance. She has 25 years’ of experience in global organizations such as Molex Inc. & Sigma Aldrich (now a subsidiary of Merck) as CFO and other senior leadership roles in finance, human resources, information systems and sourcing & procurement. Most recently Vanaja was responsible for establishing and leading Global Shared Services for Sigma Aldrich. Vanaja has significant experience leading major strategic projects through to completion. Vanaja, in her role as managing director in India, oversees the India business, focusing on its growth strategy and expansion of George Clinical’s footprint in India’s clinical research landscape.
Evon has completed her Bachelor of Science Degree in Biology at the University of Toronto and continued her Master’s studies in Nutritional Science. She has over 15 years’ experience working in the pharmaceutical industry in various fields including regulatory affairs, clinical research and project management. Prior to joining George Clinical, Evon held a clinical operations management role at Pfizer. Evon is the Associate Director of Business Operations at George Clinical managing the business activities in various countries in East Asia including Hong Kong, Malaysia, Philippines, South Korea, Taiwan, Thailand and Vietnam. Evon also oversees the next stages in the development of George Clinical’s business and operations in other Asia-Pacific regions.